Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcatheter aortic valve replacement with CoreValve.
Matthews RV, Shavelle DM. Matthews RV, et al. Among authors: shavelle dm. Cardiol Clin. 2013 Aug;31(3):351-61. doi: 10.1016/j.ccl.2013.05.007. Cardiol Clin. 2013. PMID: 23931099 Review.
Percutaneous devices to support the left ventricle.
Shavelle DM, Clavijo L, Matthews RV. Shavelle DM, et al. Expert Rev Med Devices. 2011 Nov;8(6):681-94. doi: 10.1586/erd.11.50. Expert Rev Med Devices. 2011. PMID: 22029466 Review.
Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
Shavelle DM, Banerjee S, Maini B, Schreiber TL, Kapasi N, O'Neill WW, Popma J, Matthews RV. Shavelle DM, et al. Am J Cardiol. 2018 Sep 15;122(6):966-972. doi: 10.1016/j.amjcard.2018.06.013. Epub 2018 Jun 21. Am J Cardiol. 2018. PMID: 30057231 Clinical Trial.
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ; SURTAVI Trial Investigators. Van Mieghem NM, et al. JAMA Cardiol. 2022 Oct 1;7(10):1000-1008. doi: 10.1001/jamacardio.2022.2695. JAMA Cardiol. 2022. PMID: 36001335 Free PMC article. Clinical Trial.
Use of regadenoson for measurement of fractional flow reserve.
Prasad A, Zareh M, Doherty R, Gopal A, Vora H, Somma K, Mehra A, Clavijo LC, Matthews RV, Shavelle DM. Prasad A, et al. Among authors: shavelle dm. Catheter Cardiovasc Interv. 2014 Feb 15;83(3):369-74. doi: 10.1002/ccd.25055. Epub 2013 Jul 3. Catheter Cardiovasc Interv. 2014. PMID: 23765847
176 results